Your browser doesn't support javascript.
loading
Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test.
Harada, Yohei; Sato, Akemi; Araki, Mitsugu; Matsumoto, Shigeyuki; Isaka, Yuta; Sagae, Yukari; Abe, Tomonori; Aoyagi, Yasuko; Sueoka, Eisaburo; Okuno, Yasushi; Kimura, Shinya; Sueoka-Aragane, Naoko.
Afiliación
  • Harada Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
  • Sato A; Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
  • Araki M; Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Matsumoto S; Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Isaka Y; Medical Sciences Innovation Hub Program, RIKEN Cluster for Science, Technology and Innovation Hub, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
  • Sagae Y; AI-driven Drug Discovery Collaborative Unit, RIKEN Center for Computational Science (R-CCS), HPC- and AI-driven Drug Development Platform Division, 7-1-26 Minatojimaminamimachi Chuo-ku, Kobe City, Hyogo, 650-0047, Japan.
  • Abe T; Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Aoyagi Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
  • Sueoka E; Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
  • Okuno Y; Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
  • Kimura S; Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Sueoka-Aragane N; Medical Sciences Innovation Hub Program, RIKEN Cluster for Science, Technology and Innovation Hub, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Cell Oncol (Dordr) ; 45(1): 121-134, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34997908
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor ErbB-2 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Oncol (Dordr) Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor ErbB-2 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Oncol (Dordr) Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos